학술논문
AML-522 COVALENT-101: Phase I Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/MLL1 Rearrangements, NPM1 Mutation), DLBCL, MM, and CLL/SLL (NCT05153330)
Document Type
Abstract
Author
Ravandi, Farhad; Lancet, Jeffrey; Amor, Adrian Alegre; Badar, Talha; Barrientos, Jacqueline; Bashey, Asad; Burgues, Juan Miguel Bergua; Curran, Emily; Janssen, Jeroen; Jeyakumar, Deepa; Kishtagari, Ashwin; Montesinos, Pau; Morillo, Daniel; Rosenberg, Aaron; Schiller, Gary; Ahmed, Uzma; Cacovean, Alex; Morris, Steve; Follit, Courtney; Mandap, Clarissa; Butler, Thomas; Carraway, Hetty
Source
In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S310-S311
Subject
Language
ISSN
2152-2650